Paradigm Financial Partners, LLC Pfizer Inc Transaction History

Paradigm Financial Partners, LLC

$662 Million
Q2 2024

A detailed history of Paradigm Financial Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Paradigm Financial Partners, LLC holds 40,348 shares of PFE stock, worth $1.08 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

40,348

Previous 36,388 10.88%

Holding current value

$1.08 Million

Previous $1.01 Million 11.79%

% of portfolio

0.17%

Previous 0.22%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $100,029 - $117,216	3,960 Added 10.88%	40,348 $1.13 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $86,187 - $98,971	-3,329 Reduced 8.38%	36,388 $1.01 Million
Q4 2023 Feb 05, 2024	SELL	$26.13 - $33.94 $37,078 - $48,160	-1,419 Reduced 3.45%	39,717 $1.14 Million
Q3 2023 Oct 12, 2023	BUY	$32.09 - $37.51 $12,932 - $15,116	403 Added 0.99%	41,136 $1.36 Million
Q2 2023 Jul 13, 2023	SELL	$36.12 - $41.79 $33,447 - $38,697	-926 Reduced 2.22%	40,733 $1.49 Million
Q1 2023 Apr 11, 2023	SELL	$39.39 - $51.28 $113,955 - $148,353	-2,893 Reduced 6.49%	41,659 $1.7 Million
Q4 2022 Jan 27, 2023	BUY	$41.75 - $54.5 $44,129 - $57,606	1,057 Added 2.43%	44,552 $0
Q3 2022 Nov 09, 2022	BUY	$43.76 - $53.42 $44,197 - $53,954	1,010 Added 2.38%	43,495 $1.87 Million
Q2 2022 Jul 27, 2022	SELL	$46.53 - $55.17 $298,815 - $354,301	-6,422 Reduced 13.13%	42,485 $2.27 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $107,649 - $133,391	2,353 Added 5.05%	48,907 $2.59 Million
Q4 2021 Feb 18, 2022	SELL	$41.32 - $61.25 $11.5 Million - $17 Million	-277,960 Reduced 85.65%	46,554 $2.75 Million
Q4 2021 Feb 10, 2022	BUY	$41.32 - $61.25 $11.5 Million - $17.1 Million	278,866 Added 610.91%	324,514 $19.2 Million
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $56,088 - $72,050	-1,429 Reduced 3.04%	45,648 $1.95 Million
Q2 2021 Aug 12, 2021	BUY	$35.91 - $40.68 $2,872 - $3,254	80 Added 0.17%	47,077 $1.84 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $141,930 - $160,069	-4,238 Reduced 8.27%	46,997 $1.7 Million
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $56,597 - $71,968	-1,691 Reduced 3.2%	51,235 $1.9 Million
Q3 2020 Nov 10, 2020	BUY	$31.75 - $37.25 $222,408 - $260,936	7,005 Added 15.25%	52,926 $1.94 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $25,933 - $31,460	861 Added 1.91%	45,921 $1.59 Million
Q1 2020 May 08, 2020	BUY	$27.03 - $38.62 $64,709 - $92,456	2,394 Added 5.61%	45,060 $1.56 Million
Q4 2019 Jan 29, 2020	BUY	$32.92 - $37.36 $44,409 - $50,398	1,349 Added 3.26%	42,666 $1.67 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $13,385 - $17,357	412 Added 1.01%	41,317 $1.48 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $66,748 - $74,943	-1,805 Reduced 4.23%	40,905 $1.77 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $22,725 - $24,967	-606 Reduced 1.4%	42,710 $1.81 Million
Q4 2018 Feb 12, 2019	BUY	$38.47 - $43.86 $1.67 Million - $1.9 Million	43,316 New	43,316 $1.89 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Financial Partners, LLC with notifications on news.

Account

Paradigm Financial Partners, LLC Pfizer Inc Transaction History